This course has expired. View available courses.
Oncology
Enhancing Oncology Care for Prostate Cancer in Saudi Arabia
This presentation by esteemed experts, Dr. Fouad Alnajjar and Dr. Shouki Bazarbashi, delves into the urgent matter of prostate cancer in Saudi Arabia. The alarming statistics reveal a remarkable 30% rise in incidence over the past decade, warranting immediate attention. The speakers shed light on the significance of shared decision-making in screening, specifically emphasizing the target age group of 55 and above, who should undergo annual PSA blood tests. A comprehensive overview of treatment options for localized prostate cancer is presented, encompassing active surveillance, surgery, and radiation therapy, while advanced metastatic cases predominantly rely on potent hormonal therapies. The crucial role of pharmacists in patient care is acknowledged, with a focus on managing side effects, monitoring bone health, and offering essential lifestyle guidance. With a resolute emphasis on early detection and holistic patient care, this compelling presentation serves as a rallying call in the fight against prostate cancer in Saudi Arabia.
DURATION
45 min
PROFESSION
Pharmacy
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-07-26
This presentation by esteemed experts, Dr. Fouad Alnajjar and Dr. Shouki Bazarbashi, delves into the urgent matter of prostate cancer in Saudi Arabia. The alarming statistics reveal a remarkable 30% rise in incidence over the past decade, warranting immediate attention. The speakers shed light on the significance of shared decision-making in screening, specifically emphasizing the target age group of 55 and above, who should undergo annual PSA blood tests.
A comprehensive overview of treatment options for localized prostate cancer is presented, encompassing active surveillance, surgery, and radiation therapy, while advanced metastatic cases predominantly rely on potent hormonal therapies. The crucial role of pharmacists in patient care is acknowledged, with a focus on managing side effects, monitoring bone health, and offering essential lifestyle guidance. With a resolute emphasis on early detection and holistic patient care, this compelling presentation serves as a rallying call in the fight against prostate cancer in Saudi Arabia.
This program is supported by Novartis.
Faculty
Dr. Fouad Alnajjar
Dr. Shouki Bazarbashi
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Review incidence of Prostate Cancer (PC).
- Discuss risk factors for PC.
- Describe Saudi guidelines for PC treatment.
- Integrate practice considerations for pharmacists to address rising rates of PC.
Accreditation
#
of credits: 0
Duration: 45 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
45 min
Duration
Pharmacy
Profession
0
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Review incidence of Prostate Cancer (PC).
- Discuss risk factors for PC.
- Describe Saudi guidelines for PC treatment.
- Integrate practice considerations for pharmacists to address rising rates of PC.
Unaccredited
ACCREDITATION
Oncology
Learning Category
Prostate Cancer
Topic
0
Price
2024-07-26
Expiry Date
MENA
Region/Language
Course Description
This presentation by esteemed experts, Dr. Fouad Alnajjar and Dr. Shouki Bazarbashi, delves into the urgent matter of prostate cancer in Saudi Arabia. The alarming statistics reveal a remarkable 30% rise in incidence over the past decade, warranting immediate attention. The speakers shed light on the significance of shared decision-making in screening, specifically emphasizing the target age group of 55 and above, who should undergo annual PSA blood tests.
A comprehensive overview of treatment options for localized prostate cancer is presented, encompassing active surveillance, surgery, and radiation therapy, while advanced metastatic cases predominantly rely on potent hormonal therapies. The crucial role of pharmacists in patient care is acknowledged, with a focus on managing side effects, monitoring bone health, and offering essential lifestyle guidance. With a resolute emphasis on early detection and holistic patient care, this compelling presentation serves as a rallying call in the fight against prostate cancer in Saudi Arabia.
This program is supported by Novartis.
Faculty
Dr. Fouad Alnajjar
Dr. Shouki Bazarbashi
Accreditation
<!–
This program is accredited by the Saudi Commission for Health Specialties for 2.0 CPD Hour(s).
Activity Accreditation Number: ACA-20230002488.
Credits are reported to the Saudi Commission for Health Specialties on a monthly basis. Please ensure that your Saudi Commission ID is accurate in your profile and allow sufficient time for credits to appear in your Mustamir account.
–>
45 min
Duration
0
Price
0
# of credits
